IndyCar Driver Makes Pit Stop at UC Cancer Institute
Just days before the 98th running of the Indianapolis 500, IndyCar driver Pippa Mann visited with researchers and clinicians at University of Cincinnati Cancer Institute.
Mann, who drives a pink Susan G. Komen Verizon IndyCar series car, partnered with the Susan G. Komen Foundation for a visit to the lab of Xiaoting Zhang, PhD, associate professor in the UC Department of Cancer Biology. The visit, held Tuesday, May 20, was part of the Indianapolis 500's annual media day, when each of the 33 drivers travel across the country to make appearances and meet with journalists.
Zhang is a Komen-supported researcher with the Cincinnati Cancer Center and UC Cancer Institute. He uses nanoparticles to study why certain cancers become resistant to the drug tamoxifen.
Following a tour of Zhang's lab in the Vontz Center for Molecular Studies, Mann visited clinicans at the UC Health Barrett Center. Elyse Lower, MD, director of the UC Cancer Institute's Comprehensive Breast Cancer Center and professor in the hematology oncology division at UC, led Mann on a tour through areas newly renovated through the Rooms that Rock for Chemo project.
Mann took to social media during her trip to Cincinnati and from her Twitter account ( @PippaMann), posted to her nearly 18,000 followers: "Amazing tour with @SusanGKomen co-sponsored researcher Dr. Zhang at @uofcincy. Massively important work. #breastcancer #500MediaDay."
Xiaoting Zhang, PhD (left), with IndyCar driver Pippa Mann.
Xiaoting Zhang, PhD (left), with IndyCar driver Pippa Mann and Elyse Lower, MD (right).
Tags
Related Stories
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
August 10, 2026
Dr. Sara Medek, a UC radiation oncology professor, speaks with Local 12 news about a new clinical trial aimed at reducing radiation in certain areas while still treating cancer effectively but with fewer painful side effects.
Cancer Center director charts future based on collaboration, AI
August 10, 2026
David Gius, MD, PhD, was featured in a Cincinnati Business Courier article and The Cancer Letter’s “The Directors" podcast discussing his priorities and goals as he recently took the helm as director of the University of Cincinnati Cancer Center.
Bidirectional link between oral, kidney health calls for patient education, access
August 4, 2026
Despite growing awareness of the connection between oral health and chronic health conditions, patient awareness and access to dental care remain limited, according to University of Cincinnati experts who recently spoke with Healio | Nephrology News & Issues.